본문으로 건너뛰기
← 뒤로

Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.

1/5 보강
Urology practice 📖 저널 OA 10.7% 2025: 3/10 OA 2026: 0/17 OA 2025~2026 2026 Vol.13(3) p. 228-229 Medication Adherence and Compliance
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-04-29
OpenAlex 토픽 · Medication Adherence and Compliance Prostate Cancer Treatment and Research Advanced Causal Inference Techniques

Wassersug R, Sears C, Schellhammer P, Watson R

이 논문을 인용하기

↓ .bib ↓ .ris
APA Richard J. Wassersug, Carly Sears, et al. (2026). Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.. Urology practice, 13(3), 228-229. https://doi.org/10.1097/UPJ.0000000000000967
MLA Richard J. Wassersug, et al.. "Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.." Urology practice, vol. 13, no. 3, 2026, pp. 228-229.
PMID 41729575 ↗

같은 제1저자의 인용 많은 논문 (1)